A Fresenius Medical Care AG dialysis machine stands inside a Fortis Healthcare India Renkare dialysis clinic in New Delhi (Photographer: Prashanth Vishwanathan/Bloomberg)

IHH Healthcare Extends Acceptance Period Of Revised Offer For Fortis

Malaysian firm IHH Healthcare Berhard today said it has extended the acceptance period of its enhanced revised proposal for Fortis Healthcare to May 29 after which it will lapse.

In a letter to the board of Fortis Healthcare, IHH Healthcare said it remains strongly committed to participate in bid for Fortis and is therefore very keen to understand the next steps the board is considering in the wake of the modified Manipal offer.

“If there is indeed a new bid process that the Board is proposing to initiate, we would like to participate in such a process and request that we be kept informed of any developments regarding the same,” IHH Healthcare’s Managing Director and Chief Executive Officer Tan See Leng said in the letter.

"We fully respect any such process that is run by the board and reiterate that we wish to engage with the Board and the shareholders of Fortis in identifying a mutually-beneficial and optimal solution," he added.

Also read: Fortis Board Backs Munjals And Burmans In Takeover Battle

In light of the expiry of the company's enhanced revised proposal on May 15, it extended the acceptance period of the same until May 29 after which it shall lapse, the letter said.

The letter, however, emphasised that the enhanced revised proposal by IHH must be accepted in its entirety and cannot be accepted together or in conjunction with any other investment proposal from any third party.

IHH Healthcare had increased its offer to invest directly in Fortis Healthcare to Rs 175 per share on May 1. It had initially made a non-binding offer to invest in Fortis at Rs 160 per share.

Also read: Fortis Says IHH Raises Offer Bid To Rs 175/Share

On April 24, IHH revised it to binding offer to immediately infuse Rs 650 crore by way of a preferential issue and allotment of equity shares at Rs 160 per share in FHL as part of an overall proposal to invest Rs 4,000 crore.

Earlier this week, Manipal-TPG combine revised their offer for the cash-strapped healthcare chain with a proposal to invest in the company at Rs 180 per share, thereby increasing valuation of the company to Rs 9,403 crore.

Also read: Manipal Health’s Revised Bid Offers Greater Value To Fortis Shareholders, Says Chairman

As many as five suitors were in the race for Fortis but after the company's board decided to evaluate only binding offers, Malaysia's IHH Healthcare Berhad, Munjal-Burmans, Manipal-TPG and KKR-backed Radiant Life Care put in their bids.

The fifth bidder, Fosun Health Holdings, an arm of Fosun International, which made a non-binding proposal to invest a total of $350 million (over Rs 2,295 crore) at a price up to Rs 156 per share, had not revised its offer.